ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,164.12
-0.19%
Dow Jones
39,118.86
-0.12%
Gold vs US Dollar
2,326.73
0.00%
Brent Oil
84.85
0.00%
Bitcoin
60,851.20
0.89%
Pepperstone
Advertisement
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Atossa Therapeutics Inc (ATOS) Share Price

ATOS Atossa Therapeutics Inc

1.1905
0.0505 (4.43%)
29 Jun 2024 - Closed
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Atossa Therapeutics Inc NASDAQ:ATOS NASDAQ Common Stock  
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   0.0505 4.43 1.1905 1.19 1.23 1.30 1.14 1.18 16,831,014 23:38:08   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Pharmaceutical Preparations  -30.09M -0.2393 -4.97 149.65M
 Type  Size  Price  Time  Units 
 20 1,500 1.1905 23:38:08 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore ATOS News
28/06/202413:30GLOBEAtossa Therapeutics Announces Updated Protocol for Clinical Trial Evaluating (Z)-Endoxifen in Combination with Abemaciclib (VERZENIO®) in Women with ER+/HER2- Breast Cancer
17/06/202413:30GLOBEAtossa Set to Join Russell 3000® Index Effective June 28, 2024
05/06/202413:30GLOBEAtossa to Present at the Sidoti Small-Cap Investor Conference
28/05/202413:30GLOBEAtossa Therapeutics Announces Support of Clinical Study Testing New, Artificial Intelligence, Breast Cancer Risk Assessment Model
24/05/202405:15EDGAR2Form EFFECT - Notice of Effectiveness
23/05/202414:00EDGAR2Form DEF 14A - Other definitive proxy statements
15/05/202413:30GLOBEAtossa Therapeutics Announces Last Patient, Last Dose in its Phase 2 Karisma-Endoxifen Clinical Trial
Period
Draw mode
Data Downloads for ATOS

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Atossa Therapeutics Inc Articles